Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis

Pei Jin¹ , Juan Zhang¹ , Percy F Sumariwalla² , Irene Ni¹ , Brett Jorgensen¹ , Damian Crawford² , Suzanne Phillips³ , Marc Feldmann² , H Michael Shepard¹ and Ewa M Paleolog²

¹Receptor BioLogix, Inc., Palo Alto, CA 94303, USA

²Kennedy Institute of Rheumatology, Faculty of Medicine, Imperial College London, London W6 8LH, UK

³Gentris Corporation, Morrisville, NC 27560, USA

author email corresponding author email

Arthritis Research & Therapy 2008, 10:R73doi:10.1186/ar2447


Published:	1 July 2008

Additional files

Additional file 1:

A Word file Summarizing the information of the 60 full-length novel splice variants with GenBank accession numbers.

Format: DOC Size: 92KB Download file

This file can be viewed with: Microsoft Word Viewer

Additional file 2:

A Word file containing a table presenting the cDNA sequences of the 60 full-length novel splice variants that have been deposited with GenBank.

Format: DOC Size: 529KB Download file

This file can be viewed with: Microsoft Word Viewer